Search

Ronald G Jubin

from Watchung, NJ
Age ~59
Get Report
Also known as:
Ron G Jubin
Phone and address:
12 Upper Dr, Plainfield, NJ 07069
(908) 753-9407
Related to:
Sonia R Cermak, 40Lexa X Regan, 74Karen A HenryAshley L Abines, 37Karen A Kopack, 57Allan D Kopack, 63Deborah A Henry, 57Kimberly J Kopack, 58Thomas Cermak, 69Pamela J Kopack, 80Hernie J Abines, 39Karen A Jubin, 56Rangy L Abines, 44Peter F KopackPatricia Wilton Kopack, 79Kacey KopackThomas J Cermak, 39Christopher A Henry, 59Cirila Abines
Connected to:
Cheree D Jubin, 56Jessica L Jubin, 36Amber Jubinsky, 45Erin E Jubinsky, 38Rosemary A Jubinsky, 92Jeanne E Jubinville, 63Mark S Jubinville, 67Timothy P Jubinville, 54Sadika Jubo, 44Michelle A Jubran, 68

Ronald Jubin Phones & Addresses

  • 12 Upper Dr, Watchung, NJ 07069 (908) 753-9407
  • 25 Birchwood Ln, Watchung, NJ 07069
  • Plainfield, NJ
  • Cranford, NJ
  • Newburyport, MA
  • Scotch Plains, NJ
  • Elizabeth, NJ
  • 12 Upper Dr, Watchung, NJ 07069 (732) 890-3326

Work

Position: Sales Occupations

Education

Degree: Bachelor's degree or higher

Emails

r***[email protected]

Publications

Us Patents

Interferons Of Rhesus And Cynomolgus Origin And Uses Thereof

View page
US Patent:
7956161, Jun 7, 2011
Filed:
Apr 11, 2008
Appl. No.:
12/082815
Inventors:
Michael A. Skawinski - Fanwood NJ, US
Doranelly Koltchev - West Windsor NJ, US
Ronald Jubin - Watchung NJ, US
William A. Clark - Matawan NJ, US
Thomas B. Lavoie - Califon NJ, US
Sidney Pestka - North Caldwell NJ, US
Assignee:
Pestka Biomedical Laboratories, Inc. - Piscataway NJ
International Classification:
C07K 14/52
C07K 14/00
G01N 33/53
A61K 38/21
A61K 38/00
US Classification:
530351, 530350, 436501, 424 854, 424 857, 514 12
Abstract:
Disclosed are interferons of Rhesus and Cynomolgus origin and methods of production and use thereof.

Assay For Determining Inhibitors Of Atpase

View page
US Patent:
57597952, Jun 2, 1998
Filed:
Mar 8, 1996
Appl. No.:
8/612987
Inventors:
Ronald G. Jubin - Watchung NJ
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
C12Q 142
US Classification:
435 21
Abstract:
This invention provides materials and methods for identifying inhibitors of a Hepatitis C Virus NS3 protein ATPase. Methods for making and purifying such an ATPase are also provided by this invention.

Pegylated Granulocyte Colony Stimulating Factor (Gcsf)

View page
US Patent:
20160361426, Dec 15, 2016
Filed:
Jun 13, 2016
Appl. No.:
15/181333
Inventors:
- South Plainview NJ, US
Ronald G. Jubin - Watchung NJ, US
Peter J. Buontempo - Westfield NJ, US
Friedericke Kazo - New Ipswich NH, US
International Classification:
A61K 47/48
A61K 38/19
Abstract:
This invention relates to novel PEGx-GCSF conjugates, wherein x is the amount of PEG per GCSF and ranges from 4 to 8. The invention also relates to PEG[x]-GCSF populations of individual PEGx-GCSF conjugates, wherein [x] is the average amount of PEG per GCSF of the population and is 4 or greater. The inventive compositions have unexpected therapeutic efficacy, while avoiding or substantially reducing the likelihood of adverse side effects.

Hemoglobin Compositions

View page
US Patent:
20150031599, Jan 29, 2015
Filed:
Aug 4, 2014
Appl. No.:
14/451232
Inventors:
- South Plainfield NJ, US
Glenn Kazo - New Ipswich NH, US
Friedericke Kazo - New Ipswich NH, US
Ronald G. Jubin - Watchung NJ, US
International Classification:
A61K 47/48
A61K 38/42
US Classification:
514 15, 514 151, 514 16, 514 18, 514 134
Abstract:
The invention provides compositions containing hemoglobin, particularly PEGylated hemoglobin. The PEGylated hemoglobin molecule is capable of transferring oxygen or carbon monoxide bound thereto to a tissue or red blood cells with which it is in proximity. Exemplary PEGylated hemoglobin formulations of the invention are virally inactivated. Various compositions of the invention include hemoglobin, which may be conjugated with one or more water-soluble polymer. PEGylated hemoglobin includes those species in which the iron atom of the hemoglobin molecule is not bound to oxygen or any other species, and hemoglobin molecules in which a species other than oxygen, e.g., carbon monoxide, is bound to the iron atom. The compositions of the invention are formulated as hypo-, iso- or hypertonic solutions of the PEGylated hemoglobin. The compositions are of use to treat and/or ameliorate disease, injury and insult by providing for the oxygenation of tissues and/organs.
Control profile
Ronald G Jubin from Watchung, NJ, age ~59 Get Report